Skip to content
RDL Network logo
A Long-Term Trial of the Effectiveness and Safety of Atypical Antipsychotic Agents in Augmenting SSRI-Refractory Obsessive-Compulsive Disorder — Hisato Matsunaga (2009) | RDL Network